CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Irvine, CA.
Industry, Sector and Symbol
Industry Freight transportation arrangement
Sub-IndustryN/A
SectorTransportation
Phone949-470-2300
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$19.63 million
Profitability
Miscellaneous
EmployeesN/A
Next Earnings Date5/2/2019 (Estimated)
OptionableOptionable
CryoPort (NASDAQ:CYRX) Frequently Asked Questions
What is CryoPort's stock symbol?
CryoPort trades on the NASDAQ under the ticker symbol "CYRX."
How were CryoPort's earnings last quarter?
CryoPort Inc (NASDAQ:CYRX) posted its earnings results on Thursday, March, 7th. The consumer goods maker reported ($0.08) earnings per share for the quarter, meeting the Thomson Reuters' consensus estimate of ($0.08). The consumer goods maker had revenue of $5.69 million for the quarter, compared to analyst estimates of $5.62 million. CryoPort had a negative return on equity of 33.40% and a negative net margin of 48.69%. View CryoPort's Earnings History.
When is CryoPort's next earnings date?
What price target have analysts set for CYRX?
4 Wall Street analysts have issued 12 month price objectives for CryoPort's shares. Their predictions range from $16.00 to $22.00. On average, they expect CryoPort's share price to reach $19.75 in the next twelve months. This suggests a possible upside of 44.1% from the stock's current price. View Analyst Price Targets for CryoPort.
What is the consensus analysts' recommendation for CryoPort?
4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CryoPort in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CryoPort.
Has CryoPort been receiving favorable news coverage?
News articles about CYRX stock have been trending positive this week, according to InfoTrie. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. CryoPort earned a daily sentiment score of 2.6 on InfoTrie's scale. They also gave news coverage about the consumer goods maker a news buzz of 3.0 out of 10, meaning that recent press coverage is unlikely to have an effect on the company's share price in the near future.
Who are some of CryoPort's key competitors?
What other stocks do shareholders of CryoPort own?
Who are CryoPort's key executives?
CryoPort's management team includes the folowing people:
- Jerrell W. Shelton, Chairman, President & Chief Executive Officer
- Phil Wilson, SVP-Global Operations & Supply Chain
- Robert S. Stefanovich, Chief Financial Officer, Secretary & Treasurer
- Bret Bollinger, Chief Technology Officer
- Mark W. Sawicki, Chief Commercial Officer
Who are CryoPort's major shareholders?
CryoPort's stock is owned by many different of institutional and retail investors. Top institutional investors include Roubaix Capital LLC (0.43%) and Conestoga Capital Advisors LLC (0.09%). Company insiders that own CryoPort stock include Jerrell Shelton and Richard J Berman. View Institutional Ownership Trends for CryoPort.
Which major investors are buying CryoPort stock?
How do I buy shares of CryoPort?
Shares of CYRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is CryoPort's stock price today?
One share of CYRX stock can currently be purchased for approximately $13.71.
How big of a company is CryoPort?
CryoPort has a market capitalization of $420.57 million and generates $19.63 million in revenue each year. The consumer goods maker earns $-9,560,000.00 in net income (profit) each year or ($0.31) on an earnings per share basis.
What is CryoPort's official website?
How can I contact CryoPort?
CryoPort's mailing address is 17305 DAIMLER STREET, IRVINE CA, 92614. The consumer goods maker can be reached via phone at 949-470-2300 or via email at [email protected]
MarketBeat Community Rating for CryoPort (NASDAQ CYRX)
MarketBeat's community ratings are surveys of what our community members think about CryoPort and other stocks. Vote "Outperform" if you believe CYRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CYRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
